Physician

Jeffrey Joseph Leinfelder, M.D.

According to 2025 Medicare claims, Jeffrey Leinfelder, M.D. (NPI: 1629175369) practices ophthalmology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is CENTRAL TEXAS EYE CLINIC, PA (NPI: 1487714374; TIN: 742506452) and primary practice location at 76710-5592.

Leinfelder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,255 traditional Medicare patients, billed 2,326 HCPCS/CPT codes, and received $209,114 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 2,459 prescription claims across 494 beneficiaries totaling $219,127 in drug costs, led by Lumigan (Bimatoprost). DME data shows 34 claims. Open Payments data shows 3 records totaling $180. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,653	3,036	$238,332
2016	1,808	3,595	$317,280
2017	1,912	3,804	$333,001
2018	1,761	3,437	$289,622
2019	1,811	3,330	$277,086
2020	1,596	2,934	$268,776
2021	1,562	2,944	$301,326
2022	1,430	2,527	$258,690
2023	1,343	2,579	$234,512
2024	1,255	2,326	$209,114

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	394	1,630	$192,577
2016	531	1,987	$269,954
2017	539	2,203	$313,979
2018	405	1,962	$269,582
2019	487	2,363	$333,916
2020	537	2,336	$347,778
2021	510	2,036	$292,254
2022	442	1,950	$255,869
2023	464	2,163	$257,909
2024	494	2,459	$219,127

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	145	145	$9,826
2017	198	201	$12,087
2018	128	128	$8,307
2019	72	72	$4,390
2020	49	49	$2,821
2021	77	80	$5,365
2022	148	169	$8,729
2023	86	94	$6,286
2024	34	34	$2,467

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92004	New patient complete exam of visual system	123	123	$84
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	379	467	$75
92014	Established patient complete exam of visual system	633	645	$73
92083	Exam of visual field with extended testing	108	110	$40
76519	Ultrasound scan to determine eye length and lens power	214	387	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	140	7,070	$59,984
Restasis	Cyclosporine	24	1,665	$34,790
Simbrinza	Brinzolamide/Brimonidine Tart	86	4,272	$21,348
Rhopressa	Netarsudil Mesylate	41	1,995	$18,856
Latanoprost	Latanoprost	1,026	52,043	$9,327

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	13	13	$1,375
V2020	Frames, purchases	N	21	21	$1,093

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$180	Bausch & Lomb Americas Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Joseph Leinfelder, M.D.?

Tedicare shows public-source Medicare data for Jeffrey Joseph Leinfelder, M.D. (NPI 1629175369), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Joseph Leinfelder, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Joseph Leinfelder, M.D.?

Jeffrey Joseph Leinfelder, M.D. is linked to CENTRAL TEXAS EYE CLINIC, PA (billing NPI 1487714374) in the available physician profile data.

Does Jeffrey Joseph Leinfelder, M.D. have Open Payments data?

Jeffrey Joseph Leinfelder, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.